
Hospitals with low-risk surgical aortic valve replacement (SAVR) programs also achieved better outcomes for transcatheter aortic valve replacement (TAVR) programs.
A new cohort study published in JAMA Cardiology included patients (65 and older) and used CMS Medicare Provider and Review data collected between 2010 and 2015. The researchers measured hospital risk-adjusted 30-day mortality after surgery as a surrogate for SAVR quality, and then examined 30-day and 1-year risk-adjusted TAVR rates and stratified them into quartiles based on hospital risk-adjusted SAVR mortality. A total of 51,924 TAVR procedures were performed.
Hospitals with higher #SAVR mortality rates also had higher short- and long-term #TAVR mortality after initiating TAVR programs. https://t.co/QgKSq1Egju pic.twitter.com/2GkLWQigJv
— JAMA Cardiology (@JAMACardio) January 21, 2019